NCT00269958View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

208

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 1991

Conditions

Anemia

Interventions

DRUG

epoetin alfa

All Listed Sponsors

lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00269958 - A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery | Biotech Hunter | Biotech Hunter